Platelet doppelgängers tackle thrombosis and cancer metastasis

February 13, 2019

Anne-Laure Papa and colleagues have created decoys of platelets - the body's clot-forming blood cells - that prevented the formation of dangerous blood clots in vessels (or thrombosis) and combated cancer metastasis in preclinical models. Their decoys - whose effects can be reversed far faster compared to standard antiplatelet drugs - represent a promising therapeutic strategy for treating thrombosis and cancer metastasis, two leading causes of death and disability worldwide. Platelets play a vital role in the human circulatory system, as they protect the body from bleeding and maintain the integrity of blood vessels. However, hyperactive platelets also contribute to an array of diseases - patients with thrombosis often have elevated platelet counts, which can also promote the spread of malignant cancer cells. Currently available antiplatelet drugs can inhibit platelet activation, but reversal of the effects they exert requires at least one week, making them risky for patients who have suffered a trauma or other life-threatening situations. To overcome this obstacle, Papa et al. created a rapidly reversible antiplatelet therapy inspired by platelet "decoys." The decoys did not aggregate and became activated in the same manner as normal platelets but maintained their ability to interact with other cells. They also inhibited harmful adhesion and aggregation of functional platelets and reduced the severity of thrombosis in a rabbit model. Importantly their effects were immediately reversed with an injection of fresh, functional platelets. They also displayed wide-ranging anticancer effects - the decoys broke up platelet-mediated aggregation of human breast cancer cells, prevented their spread in a chip model of the human vasculature, and inhibited metastatic tumor growth in mice. The fast reversibility of the therapy indicates it could one day prevent life-threatening bleeding in clinical emergencies or surgical settings, the authors say.

American Association for the Advancement of Science

Related Platelets Articles from Brightsurf:

Exploring connections between ovarian cancer and blood cells
Recent discoveries made by researchers at Texas A&M University could change the way ovarian cancer is understood and treated.

COVID-19 causes 'hyperactivity' in blood-clotting cells
Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists.

Novel function of platelets in tumor blood vessels found
Scientists at Uppsala University have discovered a hitherto unknown function of blood platelets in cancer.

Platelets exacerbate immune response
Platelets not only play a key role in blood clotting, but can also significantly intensify inflammatory processes.

Blood platelets trigger events that cause organ damage after heart surgery
Damage to kidneys and other organs after heart surgery is not so much triggered by the surgical repair of the heart itself but rather by the massive inflammatory response, which arises from multiple factors: the machinery used to keep blood and oxygen flowing, changes of blood flow during the surgery, and tissue responses to the surgical trauma.

Platelets instead of spheres make screens more economical
ETH scientists have further developed QLED technology for screens. They have produced light sources that for the first time emit high-intensity light in only one direction.

Study: Blood-clotting protein and blood platelets promote immune evasion, cancer progression
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G.

Blocking platelets: A possible option to prevent fatty liver disease and liver cancer
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg and from Zurich University and University Hospital have now shown in a publication.

Platelet doppelgängers tackle thrombosis and cancer metastasis
Anne-Laure Papa and colleagues have created decoys of platelets -- the body's clot-forming blood cells -- that prevented the formation of dangerous blood clots in vessels (or thrombosis) and combated cancer metastasis in preclinical models.

Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

Read More: Platelets News and Platelets Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to